162 related articles for article (PubMed ID: 7686120)
1. Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.
Genesca J; Esteban JI; Quer J; Viladomiu LL; Gonzalez A; Esteban R; Guardia J
Gut; 1993; 34(2 Suppl):S62-3. PubMed ID: 7686120
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
Tassopoulos NC; Koutelou MG; Papatheodoridis G; Polychronaki H; Delladetsima I; Giannikakis T; Todoulos A; Toliopoulos A; Hatzakis A
Gut; 1993; 34(2 Suppl):S130-2. PubMed ID: 7686113
[TBL] [Abstract][Full Text] [Related]
3. A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C.
Lampertico P; Rumi M; Romeo R; Craxì A; Soffredini R; Biassoni D; Colombo M
Hepatology; 1994 Jan; 19(1):19-22. PubMed ID: 7506225
[TBL] [Abstract][Full Text] [Related]
4. Mooren-type hepatitis C virus-associated corneal ulceration.
Wilson SE; Lee WM; Murakami C; Weng J; Moninger GA
Ophthalmology; 1994 Apr; 101(4):736-45. PubMed ID: 7512254
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C.
Hwang SJ; Lee SD; Chan CY; Lu RH; Lo KJ
J Hepatol; 1994 Nov; 21(5):831-6. PubMed ID: 7890900
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
Quiroga JA; Herrero M; Castillo I; Navas S; Pardo M; Carreño V
J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
[TBL] [Abstract][Full Text] [Related]
7. The use of recombinant interferon alfa-2b in elderly patients with anti-HCV-positive chronic active hepatitis.
Bresci G; Del Corso L; Romanelli AM; Giuliano G; Pentimone F
J Am Geriatr Soc; 1993 Aug; 41(8):857-62. PubMed ID: 7688007
[TBL] [Abstract][Full Text] [Related]
8. Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion.
Colombo M; Lampertico P; Rumi M
Gut; 1993; 34(2 Suppl):S141. PubMed ID: 8314483
[TBL] [Abstract][Full Text] [Related]
9. Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience.
Weiland O; Schvarcz R; Wejstål R; Norkrans G; Frydén A
J Hepatol; 1990; 11 Suppl 1():S57-62. PubMed ID: 2127789
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b.
Saracco G; Rosina F; Abate ML; Chiandussi L; Gallo V; Cerutti E; Di Napoli A; Solinas A; Deplano A; Tocco A
Hepatology; 1993 Dec; 18(6):1300-5. PubMed ID: 7694894
[TBL] [Abstract][Full Text] [Related]
11. Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis.
Schvarcz R; Glaumann H; Weiland O; Norkrans G; Wejstål R; Frydén A
Liver; 1991 Feb; 11(1):30-8. PubMed ID: 1646369
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon.
Shindo M; Di Bisceglie AM; Hoofnagle JH
Hepatology; 1992 Jun; 15(6):1013-6. PubMed ID: 1317338
[TBL] [Abstract][Full Text] [Related]
13. Chronic posttransfusion non-A, non-B hepatitis and autoimmune chronic active hepatitis-aspects on treatment, prognosis and relation to hepatitis C virus.
Schvarcz R
Scand J Infect Dis Suppl; 1991; 79():1-48. PubMed ID: 1658923
[No Abstract] [Full Text] [Related]
14. Effects of early interferon alfa therapy for hepatitis C virus infection recurrence after liver transplantation.
Boillot O; Berger F; Rasolofo E; Mion F; Chevallier P; Gille D; Paliard P
Transplant Proc; 1995 Aug; 27(4):2501. PubMed ID: 7544508
[No Abstract] [Full Text] [Related]
15. [The response of the hepatitis C and hepatitis G viruses to treatment with recombinant interferon alfa-2b].
Infante Pina D; Pich Rosal M; Sauleda Oliveras S; Tormo Carnice R; Esteban Mur JI; Esteban Mur R
An Esp Pediatr; 1998 Dec; 49(6):609-14. PubMed ID: 9972624
[TBL] [Abstract][Full Text] [Related]
16. Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha.
Löhr H; Nagel C; Dienes HP; Simpson B; Michel G; Goergen B; Meyer zum Büschenfelde KH; Gerken G
Hepatology; 1994 Dec; 20(6):1383-9. PubMed ID: 7526999
[TBL] [Abstract][Full Text] [Related]
17. Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.
Marcellin P; Pouteau M; Martinot-Peignoux M; Degos F; Duchatelle V; Boyer N; Lemonnier C; Degott C; Erlinger S; Benhamou JP
Gastroenterology; 1995 Jul; 109(1):156-65. PubMed ID: 7540996
[TBL] [Abstract][Full Text] [Related]
18. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
[TBL] [Abstract][Full Text] [Related]
19. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.
Poynard T; Bedossa P; Chevallier M; Mathurin P; Lemonnier C; Trepo C; Couzigou P; Payen JL; Sajus M; Costa JM
N Engl J Med; 1995 Jun; 332(22):1457-62. PubMed ID: 7739681
[TBL] [Abstract][Full Text] [Related]
20. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks.
Reichard O; Foberg U; Frydén A; Mattsson L; Norkrans G; Sönnerborg A; Wejstål R; Yun ZB; Weiland O
Hepatology; 1994 Feb; 19(2):280-5. PubMed ID: 7507462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
